Business Wire 7-Dec-2017 4:01 PM
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Biogen Inc. (NASDAQ: BIIB) announced today that it will present at the Guggenheim 5th Annual HealthcareConference. The webcast will be live on Wednesday, December 13, 2017 at 12:00 p.m. ET.To access the live webcast, please visit Biogens Investors section at www.biogen.com/investors. An archived version of the webcast will be available following the presentation.
About Biogen Through cutting-edge science and medicine, Biogen discovers, develops and delivers innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases. Founded in 1978, Biogen is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including Alzheimers disease, Parkinsons disease and amyotrophic lateral sclerosis. Biogen also manufactures and commercializes biosimilars of advanced biologics. For more information, please visit www.biogen.com. Follow us on social media Twitter, LinkedIn, Facebook, YouTube.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171207005141/en/
BiogenKaren Jewell, 781-464-2442Investor Relations
Source: Biogen Inc.
Limited Time Offer:
Claim your free copy of income expert Bryan Perry's new report:
My Top Monthly Dividend Payer (8% Dividend Yield)
You'll also receive Bryan Perry's weekly e-letter, Dividend Investing Weekly, at no cost, along with other associated financial content and special offers.